Loading…
Non-diabetic ketoacidosis secondary to primary hyperthyroidism
Introduction:. There are variable complications of hyperthyroidism, including atrial fibrillation, heart failure, osteoporosis, and thyroid storm. One infrequent complication of hyperthyroidism is non-diabetic ketoacidosis (NDKA). To the best of our knowledge, our case is the third report of NDKA re...
Saved in:
Published in: | Medicine (Baltimore) 2022-06, Vol.101 (23), p.e28253 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c1613-489abd13452883d8e4ba666ce8fda1099929879526ef849dc15064fcf0f2f16e3 |
---|---|
cites | |
container_end_page | |
container_issue | 23 |
container_start_page | e28253 |
container_title | Medicine (Baltimore) |
container_volume | 101 |
creator | Abdulrahman F. Al-Mashdali, MD Mohammadshah Gul, MD Waseem Umer, MD Abeer Omar, MBBS Akhnuwkh Jones, MD, FACP |
description | Introduction:. There are variable complications of hyperthyroidism, including atrial fibrillation, heart failure, osteoporosis, and thyroid storm. One infrequent complication of hyperthyroidism is non-diabetic ketoacidosis (NDKA). To the best of our knowledge, our case is the third report of NDKA related to thyrotoxicosis. Patient concern:. We describe a case of a 41-year-old African lady with no past medical history presented to our hospital with severe abdominal pain and vomiting for three weeks. This was associated with decreased appetite and weight loss. Diagnosis:. Laboratory findings were significant for high anion gap metabolic acidosis, positive ketones in the urine, and high serum B-hydroxybutyrate. The blood glucose readings and HbA1c were within normal limits. Also, serum lactic acid and salicylate levels were within the normal range. The diagnosis of NDKA was made. Later, the thyroid functions test (TFT) confirmed the diagnosis of primary hyperthyroidism. Intervention and outcomes:. The patient was managed initially with intravenous fluid and antiemetics. Then, she was started on propranolol and carbimazole. After which, her symptoms improved dramatically, and the metabolic acidosis (with serum ketones) were corrected within a few days of starting anti-thyroid medications. Conclusion:. Despite its rarity, NDKA can be associated with severe thyrotoxicosis. Vigorous intravenous hydration and anti-thyroid medication are the mainstay treatment. TFT should be requested in a patient with unexplained NDKA |
doi_str_mv | 10.1097/MD.0000000000028253 |
format | article |
fullrecord | <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0f5d6563aeff4ad4950e80585fb78e57</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0f5d6563aeff4ad4950e80585fb78e57</doaj_id><sourcerecordid>oai_doaj_org_article_0f5d6563aeff4ad4950e80585fb78e57</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1613-489abd13452883d8e4ba666ce8fda1099929879526ef849dc15064fcf0f2f16e3</originalsourceid><addsrcrecordid>eNpFj8tOwzAURC0EEqHwBWzyAyl-XT82SKi8KhXYwDpy7Gvq0tZVnE3-ngCVmM2MzmI0Q8g1o3NGrb55uZ_Tf3HDQZyQioFQDVglT0k1UWi01fKcXJSyoZQJzWVFbl_zvgnJdTgkX3_hkJ1PIZdU6oI-74Prx3rI9aFPu5-4Hg_YD-uxzymksrskZ9FtC14dfUY-Hh_eF8_N6u1pubhbNZ4pJhpprOsCExK4MSIYlJ1TSnk0MbjpgbXcGm2BK4xG2uAZUCWjjzTyyBSKGVn-9YbsNu1xTJtdan9B7j9b108PttjSCEGBEg5jlC5ICxQNBQOx0wZBi2-07lie</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Non-diabetic ketoacidosis secondary to primary hyperthyroidism</title><source>LWW Online</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Abdulrahman F. Al-Mashdali, MD ; Mohammadshah Gul, MD ; Waseem Umer, MD ; Abeer Omar, MBBS ; Akhnuwkh Jones, MD, FACP</creator><creatorcontrib>Abdulrahman F. Al-Mashdali, MD ; Mohammadshah Gul, MD ; Waseem Umer, MD ; Abeer Omar, MBBS ; Akhnuwkh Jones, MD, FACP</creatorcontrib><description>Introduction:. There are variable complications of hyperthyroidism, including atrial fibrillation, heart failure, osteoporosis, and thyroid storm. One infrequent complication of hyperthyroidism is non-diabetic ketoacidosis (NDKA). To the best of our knowledge, our case is the third report of NDKA related to thyrotoxicosis. Patient concern:. We describe a case of a 41-year-old African lady with no past medical history presented to our hospital with severe abdominal pain and vomiting for three weeks. This was associated with decreased appetite and weight loss. Diagnosis:. Laboratory findings were significant for high anion gap metabolic acidosis, positive ketones in the urine, and high serum B-hydroxybutyrate. The blood glucose readings and HbA1c were within normal limits. Also, serum lactic acid and salicylate levels were within the normal range. The diagnosis of NDKA was made. Later, the thyroid functions test (TFT) confirmed the diagnosis of primary hyperthyroidism. Intervention and outcomes:. The patient was managed initially with intravenous fluid and antiemetics. Then, she was started on propranolol and carbimazole. After which, her symptoms improved dramatically, and the metabolic acidosis (with serum ketones) were corrected within a few days of starting anti-thyroid medications. Conclusion:. Despite its rarity, NDKA can be associated with severe thyrotoxicosis. Vigorous intravenous hydration and anti-thyroid medication are the mainstay treatment. TFT should be requested in a patient with unexplained NDKA</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000028253</identifier><language>eng</language><publisher>Wolters Kluwer</publisher><ispartof>Medicine (Baltimore), 2022-06, Vol.101 (23), p.e28253</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1613-489abd13452883d8e4ba666ce8fda1099929879526ef849dc15064fcf0f2f16e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Abdulrahman F. Al-Mashdali, MD</creatorcontrib><creatorcontrib>Mohammadshah Gul, MD</creatorcontrib><creatorcontrib>Waseem Umer, MD</creatorcontrib><creatorcontrib>Abeer Omar, MBBS</creatorcontrib><creatorcontrib>Akhnuwkh Jones, MD, FACP</creatorcontrib><title>Non-diabetic ketoacidosis secondary to primary hyperthyroidism</title><title>Medicine (Baltimore)</title><description>Introduction:. There are variable complications of hyperthyroidism, including atrial fibrillation, heart failure, osteoporosis, and thyroid storm. One infrequent complication of hyperthyroidism is non-diabetic ketoacidosis (NDKA). To the best of our knowledge, our case is the third report of NDKA related to thyrotoxicosis. Patient concern:. We describe a case of a 41-year-old African lady with no past medical history presented to our hospital with severe abdominal pain and vomiting for three weeks. This was associated with decreased appetite and weight loss. Diagnosis:. Laboratory findings were significant for high anion gap metabolic acidosis, positive ketones in the urine, and high serum B-hydroxybutyrate. The blood glucose readings and HbA1c were within normal limits. Also, serum lactic acid and salicylate levels were within the normal range. The diagnosis of NDKA was made. Later, the thyroid functions test (TFT) confirmed the diagnosis of primary hyperthyroidism. Intervention and outcomes:. The patient was managed initially with intravenous fluid and antiemetics. Then, she was started on propranolol and carbimazole. After which, her symptoms improved dramatically, and the metabolic acidosis (with serum ketones) were corrected within a few days of starting anti-thyroid medications. Conclusion:. Despite its rarity, NDKA can be associated with severe thyrotoxicosis. Vigorous intravenous hydration and anti-thyroid medication are the mainstay treatment. TFT should be requested in a patient with unexplained NDKA</description><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpFj8tOwzAURC0EEqHwBWzyAyl-XT82SKi8KhXYwDpy7Gvq0tZVnE3-ngCVmM2MzmI0Q8g1o3NGrb55uZ_Tf3HDQZyQioFQDVglT0k1UWi01fKcXJSyoZQJzWVFbl_zvgnJdTgkX3_hkJ1PIZdU6oI-74Prx3rI9aFPu5-4Hg_YD-uxzymksrskZ9FtC14dfUY-Hh_eF8_N6u1pubhbNZ4pJhpprOsCExK4MSIYlJ1TSnk0MbjpgbXcGm2BK4xG2uAZUCWjjzTyyBSKGVn-9YbsNu1xTJtdan9B7j9b108PttjSCEGBEg5jlC5ICxQNBQOx0wZBi2-07lie</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Abdulrahman F. Al-Mashdali, MD</creator><creator>Mohammadshah Gul, MD</creator><creator>Waseem Umer, MD</creator><creator>Abeer Omar, MBBS</creator><creator>Akhnuwkh Jones, MD, FACP</creator><general>Wolters Kluwer</general><scope>DOA</scope></search><sort><creationdate>20220601</creationdate><title>Non-diabetic ketoacidosis secondary to primary hyperthyroidism</title><author>Abdulrahman F. Al-Mashdali, MD ; Mohammadshah Gul, MD ; Waseem Umer, MD ; Abeer Omar, MBBS ; Akhnuwkh Jones, MD, FACP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1613-489abd13452883d8e4ba666ce8fda1099929879526ef849dc15064fcf0f2f16e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdulrahman F. Al-Mashdali, MD</creatorcontrib><creatorcontrib>Mohammadshah Gul, MD</creatorcontrib><creatorcontrib>Waseem Umer, MD</creatorcontrib><creatorcontrib>Abeer Omar, MBBS</creatorcontrib><creatorcontrib>Akhnuwkh Jones, MD, FACP</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdulrahman F. Al-Mashdali, MD</au><au>Mohammadshah Gul, MD</au><au>Waseem Umer, MD</au><au>Abeer Omar, MBBS</au><au>Akhnuwkh Jones, MD, FACP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-diabetic ketoacidosis secondary to primary hyperthyroidism</atitle><jtitle>Medicine (Baltimore)</jtitle><date>2022-06-01</date><risdate>2022</risdate><volume>101</volume><issue>23</issue><spage>e28253</spage><pages>e28253-</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Introduction:. There are variable complications of hyperthyroidism, including atrial fibrillation, heart failure, osteoporosis, and thyroid storm. One infrequent complication of hyperthyroidism is non-diabetic ketoacidosis (NDKA). To the best of our knowledge, our case is the third report of NDKA related to thyrotoxicosis. Patient concern:. We describe a case of a 41-year-old African lady with no past medical history presented to our hospital with severe abdominal pain and vomiting for three weeks. This was associated with decreased appetite and weight loss. Diagnosis:. Laboratory findings were significant for high anion gap metabolic acidosis, positive ketones in the urine, and high serum B-hydroxybutyrate. The blood glucose readings and HbA1c were within normal limits. Also, serum lactic acid and salicylate levels were within the normal range. The diagnosis of NDKA was made. Later, the thyroid functions test (TFT) confirmed the diagnosis of primary hyperthyroidism. Intervention and outcomes:. The patient was managed initially with intravenous fluid and antiemetics. Then, she was started on propranolol and carbimazole. After which, her symptoms improved dramatically, and the metabolic acidosis (with serum ketones) were corrected within a few days of starting anti-thyroid medications. Conclusion:. Despite its rarity, NDKA can be associated with severe thyrotoxicosis. Vigorous intravenous hydration and anti-thyroid medication are the mainstay treatment. TFT should be requested in a patient with unexplained NDKA</abstract><pub>Wolters Kluwer</pub><doi>10.1097/MD.0000000000028253</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2022-06, Vol.101 (23), p.e28253 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0f5d6563aeff4ad4950e80585fb78e57 |
source | LWW Online; IngentaConnect Journals; PubMed Central |
title | Non-diabetic ketoacidosis secondary to primary hyperthyroidism |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-diabetic%20ketoacidosis%20secondary%20to%20primary%20hyperthyroidism&rft.jtitle=Medicine%20(Baltimore)&rft.au=Abdulrahman%20F.%20Al-Mashdali,%20MD&rft.date=2022-06-01&rft.volume=101&rft.issue=23&rft.spage=e28253&rft.pages=e28253-&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000028253&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_0f5d6563aeff4ad4950e80585fb78e57%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1613-489abd13452883d8e4ba666ce8fda1099929879526ef849dc15064fcf0f2f16e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |